What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer?

Q3 Medicine Advances in Surgery Pub Date : 2022-09-01 DOI:10.1016/j.yasu.2022.02.008
Anna Weiss MD , Tari A. King MD
{"title":"What Is the Role of Neoadjuvant Endocrine Therapy for Breast Cancer?","authors":"Anna Weiss MD , Tari A. King MD","doi":"10.1016/j.yasu.2022.02.008","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":38796,"journal":{"name":"Advances in Surgery","volume":"56 1","pages":"Pages 275-286"},"PeriodicalIF":0.0000,"publicationDate":"2022-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Surgery","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0065341122000082","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 2
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
乳腺癌新辅助内分泌治疗的作用是什么?
对于激素受体阳性,人表皮生长因子受体2阴性(HR + HER2-)乳腺癌的新辅助内分泌治疗(NET)的兴趣越来越大。基因组测定的广泛使用表明,许多HR + her2乳腺癌患者并没有从化疗中获益,这导致人们越来越关注NET作为一种毒性较小的替代方案。虽然NET缩小乳腺肿瘤和实现乳房保护的能力是众所周知的,但腋窝手术算法并没有明确定义。在这里,我们回顾了原发性内分泌治疗,具有里程碑意义的NET临床试验,以及NET后残留淋巴结疾病的处理。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Advances in Surgery
Advances in Surgery Medicine-Surgery
CiteScore
2.20
自引率
0.00%
发文量
24
期刊介绍: Each year, Advances in Surgery brings you the best current thinking from the preeminent practitioners in your field. A distinguished editorial board identifies current areas of major progress and controversy and invites specialists to contribute original articles on these topics. These insightful overviews bring concepts to a clinical level and explore their everyday impact on patient care.
期刊最新文献
Contents The Significance of Circulating Tumor Cells in Pancreatic Cancer Copyright Associate Editors Contributors
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1